Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment

• Status: Completed
• Trial end date: 2019-12-22
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to evaluate the effect of nebulized Midazolam, Dexmedetomidine, and their combination as procedural, moderate sedative agents in preschoolers undergoing dental treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nourhan M.Aly
• Collaborators: Alexandria University; Faculty of Dentistry, Alexandria University
• Treatments: Dexmedetomidine; Midazolam

Criteria

Inclusion Criteria:

• Age range 4-6 years

• Frankl scale score 2.

• ASA I or II physical status.

• Dental intervention under local anesthesia not requiring more than 30 minutes.

• No previous dental experience.

• Parent/guardian"s written consent.

Exclusion Criteria:

• Dental treatment indicated under general anesthesia.

• Presence of facial deformities.

• History of neurological or cognitive alterations.

• Mouth breathers.